Literature DB >> 28337967

One year in review 2017: primary Sjögren's syndrome.

Francesco Ferro1, Elisa Marcucci2, Martina Orlandi3, Chiara Baldini4, Elena Bartoloni-Bocci2.   

Abstract

Primary Sjögren's syndrome (pSS) is a complex and heterogeneous disease. Last year, a great deal of basic and clinical research was carried out in pSS. Following the previous reviews of this publishing series, we will herewith provide a critical digest of the most recent literature on pSS pathogenesis, clinical manifestations and treatment. More specifically, we will focus on the heterogeneity of the disease, on the underlying pathogenetic pathways and on the possible new targeted treatments on the horizon.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28337967

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  20 in total

1.  Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.

Authors:  Verónica C Martínez Allo; Vanesa Hauk; Nicolas Sarbia; Nicolás A Pinto; Diego O Croci; Tomás Dalotto-Moreno; Rosa M Morales; Sabrina G Gatto; Montana N Manselle Cocco; Juan C Stupirski; Ángel Deladoey; Esteban Maronna; Priscila Marcaida; Virginia Durigan; Anastasia Secco; Marta Mamani; Alicia Dos Santos; Antonio Catalán Pellet; Claudia Pérez Leiros; Gabriel A Rabinovich; Marta A Toscano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

Review 2.  Advances in the diagnosis and treatment of Sjogren's syndrome.

Authors:  Xiaoyun Chen; Huaxun Wu; Wei Wei
Journal:  Clin Rheumatol       Date:  2018-05-26       Impact factor: 2.980

3.  The validity of salivary gland scintigraphy in Sjögren's syndrome diagnosis: comparison of visual and excretion fraction analyses.

Authors:  María García-González; M Jesús González-Soto; M Ángeles Gómez Rodríguez-Bethencourt; Iván Ferraz-Amaro
Journal:  Clin Rheumatol       Date:  2020-10-19       Impact factor: 2.980

4.  Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.

Authors:  Ting Guo; Yaomei Long; Qinxue Shen; Wei Guo; Wang Duan; Xiaoli Ouyang; Hong Peng
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

5.  Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.

Authors:  Sarah Benchabane; Mourad Belkhelfa; Houda Belguendouz; Sourour Zidi; Abdelhalim Boudjelida; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-06-04       Impact factor: 4.473

6.  Primary Sjögren's Syndrome: A Retrospective Cohort Study of Burden of Illness in Sweden.

Authors:  Anna Westerlund; Anne Mette Tranberg Kejs; Heval Beydogan; Kerry Gairy
Journal:  Rheumatol Ther       Date:  2021-06-09

Review 7.  Current Insights in Microbiome Shifts in Sjogren's Syndrome and Possible Therapeutic Interventions.

Authors:  Christina Tsigalou; Elisavet Stavropoulou; Eugenia Bezirtzoglou
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

Review 8.  Laryngological manifestations of Sjögren's syndrome.

Authors:  Bartłomiej Kamiński
Journal:  Reumatologia       Date:  2019-02-28

9.  Sex Effects on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.

Authors:  Sara Tellefsen; Mathias Kaurstad Morthen; Stephen M Richards; Scott M Lieberman; Raheleh Rahimi Darabad; Wendy R Kam; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-11-01       Impact factor: 4.799

Review 10.  Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome.

Authors:  Hideki Nakamura; Yoshiro Horai; Toshimasa Shimizu; Atsushi Kawakami
Journal:  Int J Mol Sci       Date:  2018-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.